Nuvectis Pharma, Inc. NVCT
NASDAQ · United States · Health Technology
$20.82-0.30 (-1.42%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -0.30 | -0.26 | -14.5% | $0 | — | -10.8%$21.60→$19.26 |
| Q1 2026 | 2026-05-05 | -0.26 | -0.30 | +13.3% | — | — | +12.5%$8.89→$10.00 |
| Q4 2025 | 2026-02-11 | -0.31 | -0.31 | 0.0% | — | — | +0.7%$8.74→$8.80 |
| Q3 2025 | 2025-11-04 | -0.44 | -0.24 | -83.3% | — | — | -11.2%$6.36→$5.65 |
| Q4 2024 | 2025-02-25 | -0.36 | -0.25 | -44.0% | — | — | — |
| Q3 2024 | 2024-11-05 | -0.24 | -0.25 | +4.0% | — | — | — |
| Q4 2023 | 2024-03-05 | -0.41 | -0.39 | -5.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.